Anteris Technologies Global (NASDAQ:AVR – Get Free Report)‘s stock had its “overweight” rating reiterated by Cantor Fitzgerald in a research report issued to clients and investors on Friday,Benzinga reports. They presently have a $15.00 price objective on the stock. Cantor Fitzgerald’s price target would indicate a potential upside of 67.97% from the stock’s previous close.
Several other research analysts have also issued reports on the stock. Wall Street Zen upgraded shares of Anteris Technologies Global from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Barclays lifted their price objective on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a research note on Friday, May 15th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Anteris Technologies Global in a research note on Friday, May 29th. Four analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Anteris Technologies Global currently has a consensus rating of “Moderate Buy” and a consensus target price of $16.00.
Anteris Technologies Global Trading Up 0.7%
Anteris Technologies Global (NASDAQ:AVR – Get Free Report) last released its quarterly earnings results on Tuesday, August 11th. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.09). Anteris Technologies Global had a negative net margin of 4,619.27% and a negative return on equity of 110.36%. The company had revenue of $1.01 million during the quarter, compared to the consensus estimate of $1.50 million. During the same period in the prior year, the company earned ($0.58) earnings per share. As a group, research analysts predict that Anteris Technologies Global will post -1.14 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other Anteris Technologies Global news, major shareholder L1 Capital Pty Ltd sold 558,633 shares of the company’s stock in a transaction on Thursday, July 30th. The stock was sold at an average price of $8.20, for a total value of $4,580,790.60. Following the completion of the transaction, the insider owned 6,633,314 shares in the company, valued at $54,393,174.80. This represents a 7.77% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold a total of 3,000,659 shares of company stock valued at $25,174,702 over the last 90 days. 4.50% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Anteris Technologies Global
Hedge funds and other institutional investors have recently made changes to their positions in the stock. L1 Capital Pty Ltd increased its holdings in Anteris Technologies Global by 143.2% during the third quarter. L1 Capital Pty Ltd now owns 6,838,136 shares of the company’s stock worth $30,772,000 after buying an additional 4,026,136 shares during the last quarter. BlackRock Inc. purchased a new position in Anteris Technologies Global in the second quarter valued at about $56,846,000. ADAR1 Capital Management LLC grew its position in shares of Anteris Technologies Global by 205.9% during the 1st quarter. ADAR1 Capital Management LLC now owns 3,789,132 shares of the company’s stock valued at $21,030,000 after acquiring an additional 2,550,355 shares during the period. Perceptive Advisors LLC grew its position in shares of Anteris Technologies Global by 104.4% during the 1st quarter. Perceptive Advisors LLC now owns 3,425,476 shares of the company’s stock valued at $19,011,000 after acquiring an additional 1,750,000 shares during the period. Finally, Nantahala Capital Management LLC increased its stake in shares of Anteris Technologies Global by 31.9% during the 4th quarter. Nantahala Capital Management LLC now owns 2,530,910 shares of the company’s stock worth $12,629,000 after purchasing an additional 612,244 shares during the last quarter.
About Anteris Technologies Global
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
See Also
- Five stocks we like better than Anteris Technologies Global
- Inside Teledyne’s Bold Bet on the Future of Medical Imaging
- Why Are Analysts Freaking Out About Apple’s All-Glass iPhone?
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
